Schonfeld Strategic Advisors LLC Beam Therapeutics Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 10,017 shares of BEAM stock, worth $250,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,017
Previous 30,517 67.18%
Holding current value
$250,925
Previous $715,000 65.73%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$22.57 - $33.14 $462,685 - $679,370
-20,500 Reduced 67.18%
10,017 $245,000
Q2 2024

Aug 14, 2024
SELL
$21.22 - $32.66 $385,800 - $593,791
-18,181 Reduced 37.33%
30,517 $715,000
Q1 2024

May 15, 2024
BUY
$23.46 - $45.07 $544,107 - $1.05 Million
23,193 Added 90.94%
48,698 $1.61 Million
Q4 2023

Feb 14, 2024
SELL
$17.69 - $30.76 $912,220 - $1.59 Million
-51,567 Reduced 66.91%
25,505 $694,000
Q3 2023

Nov 14, 2023
BUY
$23.01 - $32.46 $49,885 - $70,373
2,168 Added 2.89%
77,072 $1.85 Million
Q2 2023

Aug 14, 2023
BUY
$29.32 - $35.99 $1.2 Million - $1.47 Million
40,839 Added 119.89%
74,904 $2.39 Million
Q1 2023

May 15, 2023
BUY
$30.15 - $48.79 $411,999 - $666,715
13,665 Added 66.99%
34,065 $1.04 Million
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $178,838 - $251,240
4,869 Added 31.35%
20,400 $797,000
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $1.69 Million - $2.98 Million
-42,369 Reduced 73.18%
15,531 $739,000
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $1.73 Million - $3.61 Million
57,900 New
57,900 $2.24 Million
Q1 2022

May 16, 2022
SELL
$53.73 - $82.16 $658,729 - $1.01 Million
-12,260 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$68.02 - $99.06 $404,855 - $589,605
5,952 Added 94.36%
12,260 $977,000
Q3 2021

Nov 16, 2021
BUY
$84.37 - $133.6 $363,465 - $575,548
4,308 Added 215.4%
6,308 $549,000
Q2 2021

Aug 16, 2021
BUY
$64.12 - $128.71 $128,240 - $257,420
2,000 New
2,000 $257,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.76B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email